181 related articles for article (PubMed ID: 27458571)
1. Sickle Cells Abolish Melanoma Tumorigenesis in Hemoglobin SS Knockin Mice and Augment the Tumoricidal Effect of Oncolytic Virus In Vivo.
Sun CW; Willmon C; Wu LC; Knopick P; Thoerner J; Vile R; Townes TM; Terman DS
Front Oncol; 2016; 6():166. PubMed ID: 27458571
[TBL] [Abstract][Full Text] [Related]
2. Exogenous sickle erythrocytes combined with vascular disruption trigger disseminated tumor vaso-occlusion and lung tumor regression.
Sun CW; Wu LC; Wankhede M; Wang D; Thoerner J; Woody L; Sorg BS; Townes TM; Terman DS
JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944254
[TBL] [Abstract][Full Text] [Related]
3. Sickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal response.
Terman DS; Viglianti BL; Zennadi R; Fels D; Boruta RJ; Yuan H; Dreher MR; Grant G; Rabbani ZN; Moon E; Lan L; Eble J; Cao Y; Sorg B; Ashcraft K; Palmer G; Telen MJ; Dewhirst MW
PLoS One; 2013; 8(1):e52543. PubMed ID: 23326340
[TBL] [Abstract][Full Text] [Related]
4. Drug-loaded sickle cells programmed ex vivo for delayed hemolysis target hypoxic tumor microvessels and augment tumor drug delivery.
Choe SW; Terman DS; Rivers AE; Rivera J; Lottenberg R; Sorg BS
J Control Release; 2013 Oct; 171(2):184-92. PubMed ID: 23871960
[TBL] [Abstract][Full Text] [Related]
5. Sickle cells produce functional immune modulators and cytotoxics.
Sun CW; Wu LC; Knopick PL; Bradley DS; Townes T; Terman DS
Am J Hematol; 2017 Oct; 92(10):981-988. PubMed ID: 28646491
[TBL] [Abstract][Full Text] [Related]
6. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia.
Belcher JD; Gomperts E; Nguyen J; Chen C; Abdulla F; Kiser ZM; Gallo D; Levy H; Otterbein LE; Vercellotti GM
PLoS One; 2018; 13(10):e0205194. PubMed ID: 30308028
[TBL] [Abstract][Full Text] [Related]
7. Critical role of C5a in sickle cell disease.
Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide loading reduces sickle red cell adhesion and vaso-occlusion in vivo.
McMahon TJ; Shan S; Riccio DA; Batchvarova M; Zhu H; Telen MJ; Zennadi R
Blood Adv; 2019 Sep; 3(17):2586-2597. PubMed ID: 31484636
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the Most Oncolytic Reovirus Strain Confer Enhanced Cell Attachment, Transcription, and Single-Step Replication Kinetics.
Mohamed A; Smiley JR; Shmulevitz M
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776267
[TBL] [Abstract][Full Text] [Related]
10. Association between oxidative stress and vascular reactivity in children with sickle cell anaemia and sickle haemoglobin C disease.
Möckesch B; Connes P; Charlot K; Skinner S; Hardy-Dessources MD; Romana M; Jumet S; Petras M; Divialle-Doumdo L; Martin C; Tressières B; Tarer V; Hue O; Etienne-Julan M; Antoine S; Pialoux V
Br J Haematol; 2017 Aug; 178(3):468-475. PubMed ID: 28466542
[TBL] [Abstract][Full Text] [Related]
11. Heme-mediated cell activation: the inflammatory puzzle of sickle cell anemia.
Guarda CCD; Santiago RP; Fiuza LM; Aleluia MM; Ferreira JRD; Figueiredo CVB; Yahouedehou SCMA; Oliveira RM; Lyra IM; Gonçalves MS
Expert Rev Hematol; 2017 Jun; 10(6):533-541. PubMed ID: 28482712
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic Viral Therapy Using Reovirus.
Thirukkumaran C; Morris DG
Methods Mol Biol; 2015; 1317():187-223. PubMed ID: 26072409
[TBL] [Abstract][Full Text] [Related]
13. Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo.
Head CA; Brugnara C; Martinez-Ruiz R; Kacmarek RM; Bridges KR; Kuter D; Bloch KD; Zapol WM
J Clin Invest; 1997 Sep; 100(5):1193-8. PubMed ID: 9276736
[TBL] [Abstract][Full Text] [Related]
14. Effect of inositol hexaphosphate-loaded red blood cells (RBCs) on the rheology of sickle RBCs.
Lamarre Y; Bourgeaux V; Pichon A; Hardeman MR; Campion Y; Hardeman-Zijp M; Martin C; Richalet JP; Bernaudin F; Driss F; Godfrin Y; Connes P
Transfusion; 2013 Mar; 53(3):627-36. PubMed ID: 22804873
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
Deng L; Fan J; Guo M; Huang B
Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
[TBL] [Abstract][Full Text] [Related]
16. A rat model for sickle cell-mediated vaso-occlusion in retina.
Lutty GA; Phelan A; McLeod DS; Fabry ME; Nagel RL
Microvasc Res; 1996 Nov; 52(3):270-80. PubMed ID: 8954868
[TBL] [Abstract][Full Text] [Related]
17. Single Amino Acid Differences between Closely Related Reovirus T3D Lab Strains Alter Oncolytic Potency
Mohamed A; Clements DR; Gujar SA; Lee PW; Smiley JR; Shmulevitz M
J Virol; 2020 Jan; 94(4):. PubMed ID: 31748391
[TBL] [Abstract][Full Text] [Related]
18. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
[TBL] [Abstract][Full Text] [Related]
19. NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.
Bar-On Y; Charpak-Amikam Y; Glasner A; Isaacson B; Duev-Cohen A; Tsukerman P; Varvak A; Mandelboim M; Mandelboim O
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724773
[TBL] [Abstract][Full Text] [Related]
20. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
